Herein, we investigated the plasma levels of MMP-9, TIMP-1 as well as the plasma activity of MMP-2 and MMP-9 in a cohort of well-characterized patients with COVID-19 at an acute stage of the disease and after three months from hospital discharge. This evidence concerns the gene TIMP1 and COVID-19.